Over the past two decades, the United States population has experienced an extraordinary increase in the rates of death from opioid overdose. A steep rise in fatal overdoses caused by pharmaceutical opioids observed over the last 15 years [1] has been overtaken by rapidly increasing rates of heroin and illicit fentanyl overdose death as the supply of prescription opioids has been reduced [2] . In 2017, there were estimated to be 68,400 drug overdose deaths in the US [3] , more than the annual number of deaths from AIDS at the height of that epidemic. These deaths have contributed to an overall decrease in life expectancy among middle-aged white people in the US [4] .
report recommended (among other things) an expansion of medication-assisted treatment for opioid dependence, but the President has so far not allocated any funds to expand treatment. He has preferred publicly appealing, low-cost strategies, including media campaigns about the dangers of opioids, reducing opioid prescriptions, and capital punishment for opioid dealers [9] . The first of these-media campaigns-will do little on its own. Regarding the second, while reducing opioid prescriptions would be useful, this approach fails to address the increasing rates of death from heroin and illicit fentanyl. Finally, the third strategy has little chance of reducing opioid deaths.
A failure to expand effective treatment will ensure that opioid overdose deaths in the US continue to increase. This is especially likely if state governments adopt other policies that will increase the risk of fatal overdoses, e.g., imprisoning more opioid users, charging opioid users with murder if they supply drugs to peers who die of an overdose [10] , and restricting the treatment offered to detoxification and drug-free rehabilitation [7] .
If the US government wants to reduce the unconscionable toll that opioid overdose deaths are taking among its citizens, then it needs to adopt the effective public health approaches advocated by expert committees [11] and commissions [8] . This should include increasing access to methadone-and buprenorphine-assisted treatment [12] and maximising their uptake by funding educational programs to reduce the stigma of addiction that discourages treatment seeking. The latter will need to address the prejudice in the community, often shared by opioid-dependent people and treatment practitioners, that drug-free approaches to treatment are the only acceptable way to treat opioid dependence.
Expanded treatment will need to be accompanied by other measures to reduce overdose deaths among opioid users who are not in treatment. These should include the distribution of the opioid antagonist naloxone to first responders and people seeking treatment for opioid dependence so that bystanders can reverse opioid overdoses and prevent deaths [13] . It may also include trials of supervised injecting facilities in locations where homelessness and streetbased injection are common [7] .
